Recent Finacing
Recent Raise
Dance Biopharm develops soft-mist inhalable biologic formulations and a connected handheld vibrating-mesh device, advancing Dance 501 inhaled recombinant human insulin and Dance 601 GLP-1 analog toward clinical development.
